Aidawati Misdar
Directeur/Bestuurslid bij International Centre For Genetic Engineering & Biotechnology
Profiel
Aidawati Misdar is currently a member of the Governors Board at the International Centre For Genetic Engineering & Biotechnology.
Actieve functies van Aidawati Misdar
| Bedrijven | Functie | Begin |
|---|---|---|
International Centre For Genetic Engineering & Biotechnology
 International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
International Centre For Genetic Engineering & Biotechnology
International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Commercial Services |
